About Us

Swiss Made

Helvetic BioPharma is an innovative biopharmaceutical company, conveniently sited in central Europe, close to the towns of Basel, Zurich and Milan, in an area with a relevant concentration of advanced pharmaceutical biotechnological companies, combined with the significant presence of a dynamic academic environment.

The site selected for the plant is strategically situated in the Mezzovico industrial park, near to the town of Lugano, Switzerland. The company specialises in manufacturing biological high value products and active compounds.

The therapeutic areas in which we are involved are, among others, Oncology, Hematology, Immuno-modulation and auto-immune diseases. The technology platform we apply includes the manufacture of recombinant proteins, synthetic peptides and monoclonal antibodies for therapeutic use.

Our activities of research, development, production, warehouse and utilities, QA and QC, administration and marketing are located on an area of about 3000 square meters . The company is fully GMP compliant, certified by Swiss Medic, the local drug authority, for manufacturing and trading pharmaceutical products.

Our worldwide commercial presence relies on many partners involved in the promotion of our product portfolio.

Helvetic BioPharma has a strategic and customer-focused approach to developing, producing and marketing high-quality affordable medicines in a sustainable way.

Our milestones

“Science knows no country,
because knowledge belongs to
humanity, and is the torch which
illuminates the world.”
(Louis Pasteur)

  • 2015

    Foundation of Helvetic BioPharma

  • 2020

    Construction of the API production plant completed

  • 2021

    GMP approval by Swiss Medic

  • 1Q 2022

    Start of GCSF manufacturing

  • 3Q 2022

    Start of PEG-GCSF manufacturing

  • 3Q 2022

    Start of the building works for the new upstream area and fill-and-finish area

  • 3Q 2024

    Start of activities of upstream and fill-and-finish